Skip to main content
logo
Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,925.00
+25.00 (0.51%)
At close: Aug 11, 2026

Finemedix Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9,8569,5239,96010,1548,1427,254
Revenue Growth
-2.28%-4.39%-1.91%24.71%12.25%-8.30%
Gross Profit
4,5324,6035,7055,6404,4063,443
Operating Income
-2,480-2,580-135.69873.58-661.25-2,313
Net Income
-1,785-1,878-24.151,176239.58-1,410
Earnings Per Share
-328.54-345.82-5.00257.0053.00-434.00
EPS Growth
---384.91%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6,2126,69110,4152,6712,5852,711
Total Debt
3,3373,9323,9304,2845,5827,115
Net Cash (Debt)
2,8752,7596,485-1,613-2,997-4,404
Net Cash Growth
-37.23%-57.45%----
Net Cash Per Share
529.23508.111342.33-352.05-665.45-1354.76

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,502-2,634170.681,378-1,435210.19
Capital Expenditures
-496.61-852.1-595.45-336.13-691.8-1,086
Free Cash Flow
-1,999-3,486-424.771,042-2,127-875.99
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.99%48.34%57.28%55.55%54.12%47.46%
Operating Margin
-25.16%-27.10%-1.36%8.60%-8.12%-31.89%
Pretax Margin
-24.95%-26.80%-2.07%11.60%3.61%-30.33%
Profit Margin
-18.11%-19.72%-0.24%11.58%2.94%-19.43%
FCF Margin
-20.28%-36.61%-4.26%10.26%-26.12%-12.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.774.287.86---